Cervical Dysplasia Market to Reach US$ 784.8 Million by 2027 with a CAGR of 7.3% - Says Coherent Market Insights

 

Cervical Dysplasia Market

The precancerous condition known as cervical dysplasia, also known as cervical intraepithelial neoplasia, is marked by abnormal cell growth on the surface lining of the cervix, the opening between the vagina and the uterus. Over the forecast period, the high prevalence of cervical cancer is anticipated to fuel growth for Cervical Dysplasia Market. For instance, cervical cancer, with an estimated 570,000 new cases in 2018 and 6.6% of all female cancers, is the fourth most common cancer in women, according to the World Health Organization.

Recommendations for HPV vaccination are anticipated to impede the expansion of the global cervical dysplasia market. Government agencies in developed nations are recommending HPV vaccination in an effort to lower the prevalence of cervical cancer. For instance, the Centers for Disease Control and Prevention (CDC) in the United States advises preteen boys and girls to receive the HPV vaccine at age 11 or 12. The Global Cervical Dysplasia Market growth is then anticipated to be hampered by this. Additionally, it is anticipated that changes in governmental regulations will impede the expansion of the global cervical dysplasia market.

The Global Cervical Dysplasia Market Is Estimated To Account For US$ 784.8 Mn In Terms Of Value By The End Of 2027.

Cervical cancer can currently be diagnosed using a number of tests, including colposcopy, Pap smear testing, and HPV testing. Colposcopy and the HPV test are the two most common procedures to confirm cervical dysplasia. Doctors have been using Pap smear tests for the past few decades to find cervix abnormalities. However, due to false negative Pap smear test results, doctors perform additional tests like the HPV test to confirm cervical cancer. As a result, governments in developed nations are changing the primary test for detecting cervical cancer.

When there is precancerous or abnormal cell growth in or around the cervix, it is called cervical dysplasia. If detected too late, the presence could result in cervical cancer. Cervical dysplasia has several main causes, one of which is the Human Papillomavirus (HPV). One of the main drivers of the cervical dysplasia market is the increase in government-funded cancer screening programmes. For instance, the first government campaign to raise awareness of cervical dysplasia screening using smear tests was introduced by Public Health England in March 2019. According to the same source, due to the stigma and fear surrounding the Pap test, the percentage of women aged 25 and older who undergo smear tests is currently at its lowest point in two decades.

According to information provided by NHS Digital, approximately 71.4% of women were screened in March 2018. PHE recently launched a campaign that involved working with national media outlets and various social media platforms to raise awareness across different platforms in England. Therefore, the government's increased efforts to improve cervical dysplasia screening are anticipated to spur market growth in the near future. One of the main drivers of the cervical dysplasia market is the rising incidence of cancer. According to a WHO report, an estimated 5, 70,000 new cases are expected to be diagnosed globally in 2018. Around the world, 3,11,000 deaths were reported in 2018.

Top Companies Mentioned are- F. Hoffmann La-Roche Ltd., QIAGEN N.V., Becton, Dickinson and Company, OncoHealth Corporation, Quest Diagnostics, Inc., Hologic, Inc., Abbott Laboratories, ASKA Pharmaceutical Co., Ltd., Asieris Pharmaceuticals, BetterLife Pharma Inc., and KinoPharma, Inc.

Get Press Release of Global Cervical Dysplasia Market

Comments

Post a Comment

Popular posts from this blog

Forging has significant application in creation of various metal for wide range of applications

Image
Forging refers to any process that produces metal from scratch by subjecting it to an external force. Metal forgers can be persons or machines. This techniques may involve grinding (for example, to produce alloyed steel) or may involve the application of pressure to apply heat to the metal piece until it is malleable. The actual process depends on various factors, including the material being forged, its shape, and the degree of stress that is placed on it. Forged grain is the product of Forging with grains of metals pushed against each other through a forge-like tool and into the cladding that forms the final shape of the metal after it has been done. It is the principal production process in most metals. It uses local or repetitive thrusts delivered by a hammer or die to apply mechanical blows to the metal piece until it becomes malleable. It is frequently classified according to the speed at which it's done: fast, cold, or hot. There are many types of forgers available today...
Read more

Ginseng Market Outlook, Analysis and forecast up to 2028

Image
  Ginseng Market Ginseng is a slow-growing perennial plant with green oval-shaped leaves and meaty roots that can persist for more than a century. Ginseng is classified into two types: American ginseng and Asian ginseng. Panax quinquefolius is the scientific name for American ginseng, whereas Panax ginseng is the scientific name for Asian ginseng. Ginseng is widely used as a herb to increase the body's energy levels. Ginseng's antioxidant and anti-inflammatory qualities serve to enhance the immune system, lowering the risk of viral and microbial infections. Ginseng also helps to lower the risk of diseases such as lung cancer, skin cancer, and liver cancer. Other health advantages of ginseng include lower blood sugar levels and improved cognitive functions such as memory and conduct. Ginseng is mostly grown in the United States, Canada, and South Korea. Ginseng has been used as a herbal medicine in China for generations, and the country is one of its largest users. Asia Pacifi...
Read more

The Vaccine Contract Manufacturing Industry to Flourish Due to Urgent Need to Develop Reliable and Cost-Effective Vaccines against Covid-19

Image
Germany Vaccine Contract Manufacturing industry is expected to witness significant growth in the near future, due to emergence of Covid-19. In Germany, from 3 January 2020 to 4:06pm CEST, 18 August 2021, there have been 3,835,375 confirmed cases of COVID-19 with 91,921 deaths, reported to WHO. As of 15 August 2021, a total of 97,884,043 vaccine doses have been administered. The increasing demand for safe and cost-effective vaccines due to unmatchable quality, consistent delivery, and unparalleled security, have contributed to the increasing growth and scope of this industry. The increasing demand for vaccines and resulting profit potential have led to significant growth in the number of contract manufacturing plants located across the world. A major focus of such plants is developing cost effective, high quality vaccines that could be made available to public health organizations and other medical organizations. Several new and innovative technologies are also being developed to man...
Read more